Pain Management in Premature Infants

Department of Pediatrics, East Tennessee State University, USA

*Corresponding Author: Des Bharti, MD, FAAP, MBA, Department of Pediatrics, East Tennessee State University, P.O. Box 70578, Johnson City, TN 37614, USA, Phone: 423-439-6222, Email: [email protected]

Received Date: April 03, 2026

Published Date: May 04, 2026

Citation: Bharti D, et al. (2026). Pain Management in Premature Infants. Mathews J Pediatr. 11(1):50.

Copyrights: Bharti D, et al. © (2026).

ABSTRACT

Pain management in premature infants is a critical component of neonatal intensive care. Preterm infants are exposed to numerous painful procedures during hospitalization, and inadequately treated pain can lead to immediate physiologic instability as well as long-term neurodevelopmental consequences. Advances in neonatal neuroscience have established that premature infants not only perceive pain but may exhibit heightened sensitivity due to immature inhibitory pathways. Repeated painful stimuli during critical periods of brain development may adversely affect neurodevelopmental outcomes. Effective pain management requires systematic assessment, preventive strategies, non-pharmacologic interventions, and judicious pharmacologic therapy. A multidisciplinary, multimodal, and family-centered approach is essential to optimize outcomes in this vulnerable population.

Keywords: Premature Infants, Neonatal Pain, Preterm Infants, Pain Management, Neonatal Intensive Care, Procedural Pain, Neonatal Analgesia, Neurodevelopment.

INTRODUCTION: MANAGEMENT OF PAIN IN PREMATURE INFANTS

Pain management in premature infants has become an important focus of neonatal care. In the past, premature infants were believed to have immature nervous systems and limited ability to perceive pain. However, research over the last several decades has clearly demonstrated that premature infants do experience pain and may actually be more sensitive to painful stimuli. Because their nervous systems are still developing, repeated painful experiences may lead to both short-term physiologic instability and long-term neurodevelopmental consequences. Therefore, careful recognition and management of pain in premature infants is essential.

Premature infants admitted to neonatal intensive care units frequently undergo numerous painful procedures. These include heel sticks, venipuncture, intravenous catheter placement, endotracheal intubation, mechanical ventilation, and ophthalmologic examinations. Very low birth weight infants may experience multiple painful procedures daily during their NICU stay. These repeated painful exposures can lead to increased stress responses, physiologic instability, and impaired recovery. Studies have shown that premature infants may undergo dozens of painful procedures during the first weeks of life, highlighting the importance of effective pain management strategies [1,2].

Premature infants are particularly vulnerable to pain because their pain pathways develop earlier than their pain-modulating systems. Peripheral nociceptors and ascending pathways are present by approximately 24 to 26 weeks of gestation, while descending inhibitory pathways mature later in infancy. This developmental imbalance results in exaggerated and prolonged pain responses. Furthermore, pain occurs during a critical period of brain development, making premature infants more susceptible to long-term effects of repeated painful experiences [3,4].

Painful stimuli in premature infants may lead to physiologic instability including increased heart rate, fluctuations in blood pressure, oxygen desaturation, and increased intracranial pressure. Stress hormone levels may also increase, which can interfere with growth and recovery. Repeated painful experiences may also disrupt sleep and feeding patterns, both of which are important for growth and development.

Untreated or inadequately treated pain in premature infants has been associated with long-term neurodevelopmental consequences. Repeated painful experiences during early brain development may affect brain structure and function. Studies have demonstrated associations between early pain exposure and altered brain maturation, reduced white matter growth, cognitive impairment, behavioral difficulties, and altered stress responses. Premature infants exposed to repeated pain may also demonstrate increased pain sensitivity later in life [5,6]. These findings emphasize the importance of early recognition and management of pain.

Because premature infants cannot verbally communicate pain, clinicians must rely on behavioral and physiologic indicators. Common signs of pain include facial grimacing, crying, changes in muscle tone, and alterations in vital signs such as heart rate and oxygen saturation. Several validated pain assessment tools have been developed to assist clinicians in identifying and quantifying pain in premature infants. These include the Premature Infant Pain Profile, Neonatal Infant Pain Scale, Neonatal Pain Agitation and Sedation Scale, and CRIES scale. Routine pain assessment should be incorporated into neonatal care to ensure timely recognition and management of pain [7,8].

Non-pharmacologic interventions are considered first-line strategies for pain management in premature infants. These interventions are safe, effective, and easy to implement. Skin-to-skin contact, also known as kangaroo care, has been shown to reduce pain responses, improve physiologic stability, and enhance parent-infant bonding. Oral sucrose is another commonly used intervention. Small amounts of sucrose given prior to procedures stimulate endogenous opioid pathways and reduce pain responses. Sucrose is often combined with non-nutritive sucking using a pacifier for improved effectiveness.

Other non-pharmacologic strategies include swaddling, facilitated tucking, breastfeeding, and use of expressed breast milk. These interventions help stabilize physiologic responses and reduce behavioral signs of pain. These methods are particularly useful for minor procedures and should be used routinely whenever possible [9-11].

Pharmacologic therapy is necessary for moderate to severe pain, invasive procedures, or postoperative care. Acetaminophen is commonly used for mild to moderate pain and postoperative discomfort. It has a favorable safety profile and minimal respiratory depression. Opioids such as morphine and fentanyl are commonly used for severe pain. Morphine provides effective analgesia but may cause respiratory depression and hypotension. Fentanyl has a rapid onset and shorter duration and is often preferred in unstable infants. Careful monitoring is essential when using opioid medications [12,13].

Sedative medications such as midazolam may be used in selected situations; however, these agents provide sedation rather than analgesia and should be used cautiously. Local anesthetics, including topical creams and local infiltration, are effective for reducing procedural pain and should be used whenever feasible [14].

Preventing pain is an important goal in neonatal care. Strategies to reduce pain exposure include minimizing unnecessary procedures, clustering care activities, using non-invasive monitoring, and ensuring skilled personnel perform procedures. Planning ahead and providing analgesia prior to procedures can significantly reduce cumulative pain exposure [2].

Current recommendations emphasize a multidisciplinary and multimodal approach to neonatal pain management. Routine pain assessment, use of non-pharmacologic interventions, careful use of pharmacologic therapy, and parental involvement are essential components of effective pain management. Family-centered care plays an important role, as parents can provide comfort through skin-to-skin care, breastfeeding, and soothing techniques. Collaboration among neonatologists, nurses, pharmacists, respiratory therapists, and parents improves outcomes and enhances quality of care [14,15].

CONCLUSION

Premature infants are uniquely vulnerable to the adverse effects of pain due to the immaturity of their developing nervous systems and the high frequency of painful exposures in the NICU. Accumulating evidence demonstrates that inadequately treated pain is associated with both immediate physiologic instability and long-term alterations in brain development, neurobehavioral outcomes, and pain sensitivity.

Effective pain management requires a proactive, structured, and evidence-based approach that integrates routine pain assessment, preventive strategies, and the judicious use of both non-pharmacologic and pharmacologic interventions. A multidisciplinary, multimodal, and family-centered model of care is essential to minimize pain and its sequelae. Active parental involvement further enhances outcomes and supports infant development.

Ongoing research, education, and implementation of standardized protocols are essential to advance neonatal pain management practices. Ensuring that pain prevention and treatment remain integral components of neonatal care will improve both immediate clinical stability and long-term developmental outcomes in this vulnerable population.

ACKNOWLEDGEMENTS

None.

CONFLICTS OF INTEREST

The authors declare that there are no conflicts of interest.

REFERENCES

1. Anand KJ, Hall RW. (2007). Controversies in neonatal pain: an introduction. Semin Perinatol. 31(5):273-274.
2. Carbajal R, Rousset A, Danan C, Coquery S, Nolent P, Ducrocq S, et al. (2008). Epidemiology and treatment of painful procedures in neonates in intensive care units. JAMA. 300(1):60-70.
3. Grunau RE, Holsti L, Peters JW. (2014). Long-term consequences of neonatal pain. Pain. 155:S55-S61.
4. Ranger M, Grunau RE. (2014). Early repetitive pain and brain development. Clin Perinatol. 41:573-591.
5. Brummelte S, Grunau RE, Chau V, Poskitt KJ, Brant R, Vinall J, et al. (2012). Procedural pain and brain development in premature newborns. Ann Neurol. 71(3):385-396.
6. Vinall J, Grunau RE. (2014). Impact of repeated pain in preterm infants. Clin Perinatol. 41:561-572.
7. Stevens BJ, Gibbins S, Yamada J, Dionne K, Lee G, Johnston C, Taddio A. (2014). The premature infant pain profile-revised (PIPP-R): initial validation and feasibility. Clin J Pain. 30(3):238-243.
8. Hillman NH, Tabrizi MN, Gauda EB. (2015). Neonatal pain assessment. Clin Perinatol. 42:529-545.
9. Johnston C, Campbell-Yeo M, Disher T, Benoit B, Fernandes A, Streiner D, et al. (2017). Skin-to-skin care for procedural pain in neonates. Cochrane Database Syst Rev. 2(2):CD008435.
10. Stevens B, Yamada J, Ohlsson A, Haliburton S, Shorkey A. (2016). Sucrose for analgesia in newborn infants undergoing painful procedures. Cochrane Database Syst Rev. 7(7):CD001069.
11. Campbell-Yeo M, Disher T, Benoit B, Johnston C. (2019). Kangaroo care and pain reduction. Clin Perinatol. 46:793-807.
12. Anand KJS, Barton BA, McIntosh N, et al. (2004). Analgesia and sedation in preterm neonates. N Engl J Med. 350:1514-1522.
13. McPherson C, Grunau RE. (2014). Neonatal pain control and neurodevelopment. Clin Perinatol. 41:895-924.
14. Committee on Fetus and Newborn and Section on Anesthesiology and Pain Medicine. (2016). Prevention and Management of Procedural Pain in the Neonate: An Update. Pediatrics. 137(2):e20154271.
15. Canadian Paediatric Society. (2023). Managing pain in newborns. Paediatr Child Health.